Clinical Trials Logo
  1. Home
  2. Osteoarthritis of Hip
  3. NCT00565786

ArCom® and ArComXL® Polyethylene Data Collection

Osteoarthritis of Hip Clinical Trial

Official title:
A Prospective Clinical Data Collection of ArCom® and ArComXL® Polyethylene

Clinical Trial Summary

The purpose of this prospective clinical data-collection is to document the performance, clinical outcomes, and wear rates of ArCom® and ArComXL® Polyethylene. The data gathered will be collated and used as a part of Biomet's post-market surveillance system and to provide feedback to designing engineers, support marketing efforts, and answer potential questions from reimbursement agencies. Inclusion/exclusion criteria are identical to those indications and contraindications stated in the FDA approved labeling for the device in 510(k) K926107 and 510(k) K043051. Surgical techniques and patient care are to be standard for the surgeons participating in the protocol.

Clinical Trial Description

The study follow-up intervals are 6 weeks, 1 year, 2 years, 3 years, 5 years, and 10 years. Demographic data is collected pre-operatively along with the Harris Hip Score and UCLA Activity Score. Operative information includes the surgical technique and other standard operative information. Follow-up information includes the Harris Hip Score, UCLA Activity Score, and Radiographic data. Anterior/posterior and frog leg lateral X-ray data is recorded to show radiolucencies, component position and angles. Sites are also required to send in an Anterior/Posterior Pelvis x-ray for wear analysis. Implant durability is documented by asking the surgeon to record revisions, complications, and device related adverse events. All information collected is de-identified in compliance with HIPAA regulations. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00565786
Study type Observational
Source Zimmer Biomet
Contact
Status Completed
Phase
Start date July 2004
Completion date January 13, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02405104 - Chlorzoxazone in Hip and Knee Arthroplasty Phase 4
Completed NCT02162186 - Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
Active, not recruiting NCT02263209 - Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty N/A
Completed NCT02577822 - The Viability of Short Stems in Total Hip Arthroplasty N/A
Active, not recruiting NCT00551967 - Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA N/A
Active, not recruiting NCT00545285 - Long-Term Multi-center Evaluation of E-Poly and Regenerex N/A
Completed NCT03966573 - Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints N/A
Recruiting NCT04754087 - G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study N/A
Completed NCT00957970 - Bone Mineral Changes Around Stemless and Stemmed Cementless Femoral Components Phase 4
Completed NCT03428893 - Mobile Technology to Support Physical Therapy Exercise N/A
Completed NCT01972594 - Pedometer Based Intervention After Total Hip Replacement-A Pilot Study N/A
Terminated NCT02161484 - Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement N/A
Withdrawn NCT01668160 - Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis N/A
Not yet recruiting NCT01040273 - Management of Postoperative Pain After Total Hip Arthroplasty Phase 2/Phase 3
Recruiting NCT02836262 - Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty N/A
Completed NCT03341442 - A Study of Posterior Hip Precautions After Total Hip Arthroplasty N/A